SCHEMBL8957398

SCHEMBL8957398

CC(O[N+](=O)[O-])C(c1ccccc1)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GSR P00390 1/20 0.51
PTGS1 P23219 3/20 0.41
PTGS2 P35354 3/20 0.41
KMT2A Q03164 4/20 0.36
KDM4E B2RXH2 1/20 0.36
MAPT P10636 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
CRHBP P24387 1/20 0.36
CRHR2 Q13324 1/20 0.36
ALDH1A1 P00352 4/20 0.35
LMNA P02545 1/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.34
ADAM17 P78536 1/20 0.34
GAA P10253 1/20 0.33
HTT P42858 1/20 0.33
F2 P00734 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1348356 0.80 GSR (0.55) GSRPTGS1PTGS2KMT2AKDM4E
Phosphine SCHEMBL28215785 0.78 GSR (0.53) GSRPTGS1PTGS2KMT2AKDM4E
SCHEMBL9838307 0.75 GSR (0.58) GSRPTGS1PTGS2KMT2ACRHBP
SCHEMBL11743677 0.74 KMT2A (0.50) GSRPTGS1PTGS2KMT2AKDM4E
SCHEMBL26614000 0.72 GSR (0.59) GSRPTGS1PTGS2KMT2AALDH1A1
SCHEMBL10403262 0.72 GSR (0.55) GSRPTGS1PTGS2KMT2AKDM4E
SCHEMBL27319378 0.72 GSR (0.69) GSRPTGS1PTGS2KMT2AALDH1A1
SCHEMBL7573943 0.71 GSR (0.35) GSRALDH1A1
Nitric Acid SCHEMBL9875242 0.71 LMNA (0.41) GSRPTGS1PTGS2KMT2AKDM4E
SCHEMBL25082860 0.70 THRB (0.42) KMT2AKDM4EALDH1A1LMNAF2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0689435-A1 USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE BYK NEDERLAND BV (NL) 1996-01-03 EP claimed
WO-1994021248-A1 USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE BYK NEDERLAND BV (NL) 1994-09-29 WO claimed
US-5049694-A Cardiovascular disorders CEDONA PHARMACEUTICALS B.V. (NL) 1991-09-17 US disclosed
EP-0359335-A2 Pharmaceutical composition having relaxing activity which contains a nitrate ester as active substance CEDONA PHARMACEUTICALS B.V. (NL) 1990-03-21 EP disclosed